| Literature DB >> 35048853 |
Yue Zhu1, Shuai Wang2, Xiaohong Gong3, Elliot K Edmiston4, Suyu Zhong5, Chao Li6, Pengfei Zhao1, Shengnan Wei6, Xiaowei Jiang6, Yue Qin3, Jujiao Kang3, Yi Wang3, Qikun Sun7, Gaolang Gong5, Fei Wang8, Yanqing Tang9.
Abstract
BACKGROUND: Schizophrenia is considered a polygenic disorder. People with schizophrenia and those with genetic high risk of schizophrenia (GHR) have presented with similar neurodevelopmental deficits in hemispheric asymmetry. The potential associations between neurodevelopmental abnormalities and schizophrenia-related risk genes in both schizophrenia and those with GHR remains unclear. AIMS: To investigate the shared and specific alternations to the structural network in people with schizophrenia and those with GHR. And to identify an association between vulnerable structural network alternation and schizophrenia-related risk genes.Entities:
Keywords: Structural network; brain asymmetry; genetic susceptibility; polygenic risk score; schizophrenia
Mesh:
Year: 2021 PMID: 35048853 PMCID: PMC8529637 DOI: 10.1192/bjp.2021.47
Source DB: PubMed Journal: Br J Psychiatry ISSN: 0007-1250 Impact factor: 9.319
Demographic and clinical characteristics of the schizophrenia, genetic high risk of schizophrenia (GHR) and healthy control groups
| Schizophrenia group | GHR group | Healthy control group | |||
|---|---|---|---|---|---|
| 97 | 79 | 192 | – | – | |
| Demographic characteristics | |||||
| Age, years: mean (s.d.) | 29.81 (9.40) | 29.52 (7.72) | 31.22 (9.85) | 1.281 | 0.279 |
| Female, | 55(56.7) | 34 (43.0) | 107 (55.7) | 4.248 | 0.120 |
| Clinical characteristics | |||||
| Duration of illness, months: mean (s.d.) | 36.69 (48.93) | — | — | – | – |
| First episode, yes: | 51(53.7) | — | — | – | – |
| Medication, yes: | 69 (71.1) | — | — | – | – |
| Hamilton Rating Scale for Depression, mean (s.d.) | 7.23 (6.35) | 2.53 (3.80) | 1.19 (2.26) | 63.568 | <0.001 |
| Hamilton Rating Scale for Anxiety, mean (s.d.) | 6.03 (7.15) | 2.03 (4.37) | 1.00 (2.52) | 32.693 | <0.001 |
| Brief Psychiatric Rating Scale, mean (s.d.) | 31.13 (11.39) | 18.92 (2.22) | 18.63 (1.93) | 118.038 | <0.001 |
Fig. 1(a) AI-Enodal among the schizophrenia, GHR and healthy control groups. (b) AI-Eglob and AI-Eloc among the schizophrenia, GHR and healthy control groups. (c) Three-dimensional representations of the Dnodal in the entire brain among the schizophrenia, GHR and healthy control groups. (d) Dnodal in the entire brain among the schizophrenia, GHR and healthy control groups. (e) Three-dimensional representations of the Enodal in the entire brain among schizophrenia, GHR and healthy control groups. (f) Enodal in the entire brain among schizophrenia, GHR and healthy control groups. (g) Eglob and Eloc in the entire brain among schizophrenia, GHR and healthy control groups.
AI, asymmetry index; ANG.L and Angular_L, left postcentral gyrus; Dnodal, nodal degree; Eglob, global efficiency; Eloc, local efficiency; Enodal, nodal efficiency; Frontal_Sup_Orb_R, right superior frontal gyrus, orbital part; IFGoperc.R and Frontal_Inf_Oper_R, right inferior frontal gyrus, opercular part; IPL.R and Parietal_Inf_R, right inferior parietal angular gyrus; HC, healthy control; GHR, genetic high risk of schizophrenia; PoCG.L and Postcentral_L, left postcentral gyrus; SOG.L and Occipital_Sup_L, left superior occipital gyrus; MFG.R and Frontal_Mid_R, right middle frontal gyrus; SZ, schizophrenia. ***P < 0.001; **P < 0.01; *P < 0.05.
Association of schizophrenia-related polygenic risk score (SZ-PRS) with asymmetry index (AI)- local efficiency (Eloc) in the schizophrenia and genetic high risk of schizophrenia (GHR) groups
| PT | 0.0001 | 0.001 | 0.01 | 0.02 | 0.03 | 0.04 | 0.05 | 0.1 | 0.2 | 0.3 | 0.4 | 0.5 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AI-Eloc | ||||||||||||
| 0.293 | 0.317 | 0.267 | 0.318 | 0.369 | 0.39 | 0.391 | 0.34 | 0.271 | 0.223 | 0.236 | 0.234 | |
| 1.25E−02 | 6.67E−03* | 2.36E−02** | 6.45E−03* | 2.11E−02** | 5.98E−02* | 4.57E−02 | 4.75E−02* |
PT, P-value thresholds.
Bold indicates significance at P < 0.05, after Bonferroni correction.
***P < 0.001; **P < 0.01; *P < 0.05.
Fig. 2(a) Significant Gene Ontology enrichment analysis for risk genes of schizophrenia-related polygenic risk scores (SZ-PRSs). (b) Significant Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis for risk genes of SZ-PRSs.
cGMP-PKG, cyclic guanosine monophosphate-protein kinase G.